Package 83774-102-01

Brand: azacitidine

Generic: azacitidine for
NDC Package

Package Facts

Identity

Package NDC 83774-102-01
Digits Only 8377410201
Product NDC 83774-102
Description

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (83774-102-01)

Marketing

Marketing Status
Marketed Since 2024-03-14
Brand azacitidine
Generic azacitidine for
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "a531999b-865f-4e84-bd6f-818f8f377a3c", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0383774102010"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["0095c67b-42f3-47e6-92db-f77843727bca"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Pilnova Pharma Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (83774-102-01)", "package_ndc": "83774-102-01", "marketing_start_date": "20240314"}], "brand_name": "AZACITIDINE", "product_id": "83774-102_a531999b-865f-4e84-bd6f-818f8f377a3c", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "83774-102", "generic_name": "azacitidine for", "labeler_name": "Pilnova Pharma Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AZACITIDINE", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA207518", "marketing_category": "ANDA", "marketing_start_date": "20240314", "listing_expiration_date": "20261231"}